Filing Flows › CVRx (CVRX) › Recalls, complaints & regulation
CVRx (CVRX): clinical trials
CVRx (CVRX) beyond its filings: 4 active clinical trials.
CVRx's latest quarter
CVRx, Q3 2026: revenue $13.8M (-6% year over year), operating margin -94.3%, net loss $14.2M, operating cash flow −$10.9M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does CVRx have?
4 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.